Central nervous system involvement in primary Sjogren syndrome

被引:8
|
作者
Ramirez, Marta [1 ]
Ramos-Casals, Manuel [1 ]
Graus, Francesc [2 ]
机构
[1] IDIBAPS, Serv Enfermedades Autoinmunes, Lab Enfermedades Autoinmunes Josep Font, Barcelona, Spain
[2] Hosp Clin Barcelona, Serv Neurol, Barcelona, Spain
来源
MEDICINA CLINICA | 2009年 / 133卷 / 09期
关键词
Sjogren syndrome; Multiple sclerosis; Myelitis; Cerebrovascular disease; ACUTE TRANSVERSE MYELOPATHY; MULTIPLE-SCLEROSIS; NEUROLOGICAL MANIFESTATIONS; NEUROMYELITIS-OPTICA; NEUROPSYCHIATRIC DYSFUNCTION; ASEPTIC MENINGOENCEPHALITIS; IMMUNOLOGICAL EXPRESSION; DIFFERENTIAL-DIAGNOSIS; INITIAL MANIFESTATION; RHEUMATIC-DISEASES;
D O I
10.1016/j.medcli.2008.12.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren syndrome (SS) is a systemic autoimmune disease that affects the exocrine glands and presents with sicca symptoms of the main mucosa surfaces. The spectrum of the disease extends from sicca syndrome to systemic involvement (extraglandular manifestations). Although earlier studies described central nervous system (CNS) involvement as a frequent extraglandular manifestation of primary SS, symptomatic CNS involvement is rarely described in recent large series (< 5%). A wide spectrum of neurological features has been described, including not only asymptomatic white matter lesions in MR examinations, but also severe focal or diffuse neurological processes. Differential diagnosis includes the coexistence of other systemic autoimmune diseases (lupus. antiphospholipid syndrome, vasculitis), cerebrovascular disease and multiple sclerosis. (C) 2008 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 50 条
  • [31] Potential involvement of the extracranial venous system in central nervous system disorders and aging
    Zivadinov, Robert
    Chung, Chih-Ping
    BMC MEDICINE, 2013, 11
  • [32] Primary angiitis of the central nervous system
    Neel, A.
    Pagnoux, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : S95 - S107
  • [33] Immune reconstitution inflammatory syndrome and the central nervous system
    Johnson, Tory
    Nath, Avindra
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (03) : 284 - 290
  • [34] The kaleidoscope of neurological manifestations in primary Sjogren's syndrome
    Alunno, A.
    Carubbi, F.
    Bartoloni, E.
    Cipriani, P.
    Giacomelli, R.
    Gerli, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S192 - S198
  • [35] Primary Central Nervous System Lymphoma in a Patient Treated With Natalizumab
    Schweikert, Andreas
    Kremer, Marcus
    Ringel, Florian
    Liebig, Thomas
    Duyster, Justus
    Stueve, Olaf
    Hemmer, Bernhard
    Berthele, Achim
    ANNALS OF NEUROLOGY, 2009, 66 (03) : 403 - 406
  • [36] Natalizumab-Associated Primary Central Nervous System Lymphoma
    Nixon, Menarvia
    Menger, Richard P.
    Kalakoti, Piyush
    Thakur, Jai Deep
    Dossani, Rimal H.
    Sharma, Kanika
    Nanda, Anil
    Guthikonda, Bharat
    WORLD NEUROSURGERY, 2018, 109 : 152 - 159
  • [37] Pulmonary Involvement in Sjogren Syndrome
    Natalini, Jake G.
    Johr, Chadwick
    Kreider, Maryl
    CLINICS IN CHEST MEDICINE, 2019, 40 (03) : 531 - +
  • [38] Primary central nervous system tumors in patients with multiple sclerosis
    Masih Sabouri
    Masoud Etemadifar
    Fatemeh Dehghani Firoozabadi
    Setayesh Sindarreh
    Amirhossein Akhavan-Sigari
    BMC Neurology, 25 (1)
  • [39] Demyelinating patterns of injury in primary central nervous system lymphoma
    Treetipsatit, Jitsupa
    Assanasen, Thamathorn
    Thorner, Paul S.
    Shuangshoti, Shanop
    ASIAN BIOMEDICINE, 2009, 3 (03) : 261 - 265
  • [40] Pulmonary Involvement in Sjogren Syndrome
    Kreider, Maryl
    Highland, Kristin
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (02) : 255 - 264